ABOUT US

QxPath, a joint venture between the Wits Health Consortium and Lancet Laboratories, was formed in July 2017 as an academic full-service medical laboratory of excellence. QxPath was officially introduced by Prof Martin Veller, Dean of the Wits Medical School, and the Chancellor of the University, Dr Judy Dlamini, at the opening of the DGMC transplant building.

The QxPath academic teaching, training and research platform is a partnership with Wits School of Pathology under the current Head, Prof Johnny Mahlangu. In addition to excellence in service, the academic platform will provide an expanded resource base of facilities and specialists in order to maximise the pathology academic output in the School.

QxPath leverages on the expertise of the Wits Health Consortium’s academic and support staff and from Lancet Laboratories’ 120 Pathologists and infrastructure. These resources will enable QxPath to deliver on its mission and build its capability to support Wits Medical school’s vision for public-private partnerships into the future.